Amgen Stock Continues to Climb on Strong Earnings and Guidance

Amgen's stock price continued to rise after beating earnings expectations and releasing strong guidance for 2026. The company's shares closed at $419.38 on August 17, 2023, up 1% from the previous day. This marks a 28.1% increase in value since an earlier reference point.

The quarterly earnings per share came in at $6.29, exceeding analyst estimates of $5.62 by $0.67. Revenue also surpassed expectations, reaching $10.05 billion for the period ending in 2026. This represents a 9.5% increase from the same quarter last year.

Amgen's net margin and return on equity were also notable, at 22.95% and 124.14%, respectively. The company's updated guidance for full-year 2026 earnings per share is between $22.30 and $23.50. Analysts see room for moderate upside if execution remains strong.

Despite the positive outlook, some market participants are reassessing risk-reward at levels above $400. Institutional holders have been adjusting positions, with asset managers reducing stakes by tens of thousands of shares while another investor initiated a position valued in millions.